Login
$OPK
$1.62 +$0.00 (0.07%) After hours

Company Executives

Officer Age In this role 2025 pay Source
Phillip Frost Also a director
CEO & Chairman
Title from the Form 4 dated Nov 21, 2025
89 Not stated $1,854,000
Adam Logal
Senior Vice President, Chief Financial Officer, Chief Accounting Officer, and Treasurer
48 Since 2014
12 years
$1,539,000
Elias A. Zerhouni Also a director
Vice Chairman and President
Title from the Form 4 dated May 27, 2025
75 Not stated $1,764,000
Jane H. Hsiao Also a director
Vice Chairman & CTO
Title from the Form 4 dated May 27, 2025
78 Not stated $1,764,000
Gary J. Nabel Also a director
Chief Innovation Officer
Title from the Form 4 dated May 27, 2025
72 Not stated Not reported
Charles W. Bishop
Chief Executive Officer of OPKO Renal
74 Since 2013
13 years
Not reported
Steven D. Rubin Also a director
Executive VP-Administration
Title from the Form 4 dated Jul 24, 2026
65 Not stated $1,574,000

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
11
serving now
Independent
6 of 6
stated in the proxy; 5 not stated
Average tenure
12.2 years
from year joined
CEO also chairs the board
Yes
Phillip Frost
Director Age On board Independent Committees Other public boards Pay Source
Phillip Frost
89 2007
19 years
Not stated None stated Cocrystal Pharma, Inc. Paid as CEO
Jane H. Hsiao
78 2007
19 years
Not stated None stated None stated Not stated
Elias A. Zerhouni
75 2022
4 years
Not stated None stated Danaher Corporation Not stated
Steven D. Rubin
65 2007
19 years
Not stated None stated Entera Bio Ltd Not stated
Gary J. Nabel
72 2022
4 years
Not stated None stated SIGA Technologies, Inc. Not stated
Prem A. Lachman
65 2021
5 years
Independent
Audit Compensation
None stated Not stated
Roger J. Medel
79 2020
6 years
Independent
Compensation
None stated Not stated
John A. Paganelli
91 2003
23 years
Independent
Audit
None stated Not stated
Richard C. Pfenniger, Jr.
70 2008
18 years
Independent
Audit · Chair
Cocrystal Pharmaceuticals, Inc. Not stated
Subbarao V. Uppaluri
76 2026
this year
Independent
Compensation · Chair
None stated Not stated
Alice Lin-Tsing Yu
82 2009
17 years
Independent None stated None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 30, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support